{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T03:52:41Z","timestamp":1772337161149,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013621","name":"American Society for Reconstructive Microsurgery","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.fertnstert.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T14:24:29Z","timestamp":1699453469000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optimal antim\u00fcllerian hormone levels in oocyte donors: a national database analysis"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-1339","authenticated-orcid":false,"given":"Papri","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Zalles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Caswell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Devine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip A.","family":"Romanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2023.11.003_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/307174a0","article-title":"The establishment and maintenance of pregnancy using in\u00a0vitro fertilization and embryo donation in a patient with primary ovarian failure","volume":"307","author":"Lutjen","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib2","unstructured":"SART national summary report;\u00a02019."},{"key":"10.1016\/j.fertnstert.2023.11.003_bib3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.fertnstert.2021.01.045","article-title":"Guidance regarding gamete and embryo donation","volume":"115","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib5","first-page":"223","article-title":"Impact of increasing antim\u00fcllerian hormone level on in\u00a0vitro fertilization fresh transfer and live birth rate","volume":"3","author":"Acharya","year":"2022","journal-title":"F S Rep"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/humrep\/deaa003","article-title":"Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank","volume":"35","author":"Hipp","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib7","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/humrep\/dep210","article-title":"Anti-Mullerian hormone (AMH): what do we still need to know?","volume":"24","author":"La Marca","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib8","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-Mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1757-2215-6-15","article-title":"Optimized protocol for cryopreservation of human eggs improves developmental competence and implantation of resulting embryos","volume":"6","author":"Wang","year":"2013","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.rbmo.2015.02.004","article-title":"Hydroxypropyl cellulose as an option for supplementation of cryoprotectant solutions for embryo vitrification in human assisted reproductive technologies","volume":"30","author":"Mori","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13039-015-0117-8","article-title":"Assessment of aneuploidy formation in human blastocysts resulting from cryopreserved donor eggs","volume":"8","author":"Deng","year":"2015","journal-title":"Mol Cytogenet"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.rbmo.2021.05.015","article-title":"Factors predicting clinical outcomes from 494 vitrified oocyte donation cycles at a UK-regulated egg bank","volume":"43","author":"Pataia","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2008-1042958","article-title":"Oocyte quality in adult polycystic ovary syndrome","volume":"26","author":"Patel","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humupd\/dmq032","article-title":"Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence","volume":"17","author":"Qiao","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.fertnstert.2010.07.1042","article-title":"Anti-Mullerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation","volume":"95","author":"Riggs","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","article-title":"Correlation of serum anti-Mullerian hormone concentrations on day 3 of the in\u00a0vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients","volume":"29","author":"Xi","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12958-020-00581-4","article-title":"High serum antiMullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology","volume":"18","author":"Tal","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/1933719115618283","article-title":"Hyperandrogenism decreases GRP78 protein level and glucose uptake in human endometrial stromal cells","volume":"23","author":"Rosas","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0035-1552582","article-title":"The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome","volume":"33","author":"Tal","year":"2015","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.fertnstert.2022.11.018","article-title":"AntiMullerian hormone is not associated with embryo ploidy in patients with and without infertility undergoing in\u00a0vitro fertilization with preimplantation genetic testing","volume":"119","author":"Stovezky","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2023.11.003_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/AOG.0b013e318163747c","article-title":"Miscarriage risk for asymptomatic women after a normal first-trimester prenatal visit","volume":"111","author":"Tong","year":"2008","journal-title":"Obstet Gynecol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028223019921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028223019921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:19:42Z","timestamp":1762150782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028223019921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0015028223019921"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2023.11.003","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal antim\u00fcllerian hormone levels in oocyte donors: a national database analysis","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92023 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}